Among other crucial alterations, RAS (KRAS, NRAS, HRAS) gene mutations are found in approximately 27% of all cancers, with high frequency of KRAS mutations in pancreatic duct adenocarcinoma, lung adenocarcinoma. Here, KRAS is linked to pancreatic ductal adenocarcinoma.